Ovarian carcinoma serum markers and ovarian steroid activity — is there a link in ovarian cancer? A correlation of inhibin, tetranectin and CA-125 to ovarian activity and the gonadotropin levels
- 1 March 1995
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 59 (1) , 53-56
- https://doi.org/10.1016/0028-2243(95)93678-h
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumorsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
- Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
- Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patientsScandinavian Journal of Clinical and Laboratory Investigation, 1993
- The pituitary-gonadal axis in women with benign or malignant ovarian tumorsActa Endocrinologica, 1992
- CA – 125, Placental Alkaline Phosphatase and Tissue Polypeptide Antigen as Preoperative Serum Markers in Ovarian CarcinomaGynecologic and Obstetric Investigation, 1992
- Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropinsGynecologic Oncology, 1991
- Tumor markers in gynecologic oncologyGynecologic Oncology, 1990
- Correlation between peripheral CA-125 levels and ovarian activity**Supported in part by the Abbott Diagnostics Division, Ottignies, Belgium.Fertility and Sterility, 1990
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990
- Relationship between ca 125 and progesterone production in women with ovarian carcinomaCancer, 1990